KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Target (TGT) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Target (TGT) over the last 17 years, with Q4 2025 value amounting to $404.0 million.

  • Target's Change in Accured Expenses rose 39876.54% to $404.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $514.0 million, marking a year-over-year increase of 49767.44%. This contributed to the annual value of $299.0 million for FY2025, which is 5887.21% down from last year.
  • According to the latest figures from Q4 2025, Target's Change in Accured Expenses is $404.0 million, which was up 39876.54% from -$159.0 million recorded in Q3 2025.
  • In the past 5 years, Target's Change in Accured Expenses ranged from a high of $939.0 million in Q1 2021 and a low of -$505.0 million during Q2 2022
  • For the 5-year period, Target's Change in Accured Expenses averaged around $34.8 million, with its median value being $66.5 million (2022).
  • Examining YoY changes over the last 5 years, Target's Change in Accured Expenses showed a top increase of 53260.87% in 2024 and a maximum decrease of 60597.01% in 2024.
  • Over the past 5 years, Target's Change in Accured Expenses (Quarter) stood at $109.0 million in 2021, then tumbled by 39.45% to $66.0 million in 2022, then soared by 300.0% to $264.0 million in 2023, then crashed by 69.32% to $81.0 million in 2024, then soared by 398.77% to $404.0 million in 2025.
  • Its last three reported values are $404.0 million in Q4 2025, -$159.0 million for Q3 2025, and -$143.0 million during Q2 2025.